AMGN
Amgen Inc.
Stock
$407.27−14.24 (−3.38%)Close Oct 1, 2026
| Shareholders' equity (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $11.7B | +57.4% | −1.6% | −11.1% |
| Shareholders' equity (Q2 2026) | $11.7B |
|---|---|
| YoY | +57.4% |
| 5-year CAGR | −1.6% |
| 10-year CAGR | −11.1% |
Shareholders' equity
| Period | Equity | YoY |
|---|---|---|
| 2025 | $8.7B | +47.3% |
| 2024 | $5.9B | −5.7% |
| 2023 | $6.2B | +70.2% |
| 2022 | $3.7B | −45.4% |
| 2021 | $6.7B | −28.8% |
| 2020 | $9.4B | −2.7% |
| 2019 | $9.7B | −22.6% |
| 2018 | $12.5B | −50.5% |
| 2017 | $25.2B | −15.5% |
| 2016 | $29.9B | +6.4% |
| 2015 | $28.1B | +8.9% |
| 2014 | $25.8B | +16.7% |
| 2013 | $22.1B | +15.9% |
| 2012 | $19.1B | +0.2% |
| 2011 | $19.0B | −20.5% |
| 2010 | $23.9B | +5.6% |
| 2009 | $22.7B | +8.5% |
| 2008 | $20.9B | +12.8% |
| 2007 | $18.5B | — |